These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 22028477)

  • 21. Hairy Cell Leukemia, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
    Wierda WG; Byrd JC; Abramson JS; Bhat S; Bociek G; Brander D; Brown J; Chanan-Khan A; Coutre SE; Davis RS; Fletcher CD; Hill B; Kahl BS; Kamdar M; Kaplan LD; Khan N; Kipps TJ; Lancet J; Ma S; Malek S; Mosse C; Shadman M; Siddiqi T; Stephens D; Wagner N; Zelenetz AD; Dwyer MA; Sundar H
    J Natl Compr Canc Netw; 2017 Nov; 15(11):1414-1427. PubMed ID: 29118233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The utility of BRAF V600E mutation-specific antibody VE1 for the diagnosis of hairy cell leukemia.
    Uppal G; Ly V; Wang ZX; Bajaj R; Solomides CC; Banks PM; Medeiros LJ; Peiper SC; Gong JZ
    Am J Clin Pathol; 2015 Jan; 143(1):120-5. PubMed ID: 25511150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BRAF(V600E) mutation together with loss of Trp53 or pTEN drives the origination of hairy cell leukemia from B-lymphocytes.
    Yap J; Yuan J; Ng WH; Chen GB; Sim YRM; Goh KC; Teo J; Lim TYH; Goay SM; Teo JHJ; Lao Z; Lam P; Sabapathy K; Hu J
    Mol Cancer; 2023 Aug; 22(1):125. PubMed ID: 37543582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of BRAF mutations in patients with hairy cell leukemia and related lymphoproliferative disorders.
    Blombery PA; Wong SQ; Hewitt CA; Dobrovic A; Maxwell EL; Juneja S; Grigoriadis G; Westerman DA
    Haematologica; 2012 May; 97(5):780-3. PubMed ID: 22133769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High resolution melting analysis for detection of BRAF exon 15 mutations in hairy cell leukaemia and other lymphoid malignancies.
    Boyd EM; Bench AJ; van 't Veer MB; Wright P; Bloxham DM; Follows GA; Scott MA
    Br J Haematol; 2011 Dec; 155(5):609-12. PubMed ID: 21910720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of the BRAF V600E mutation in Japanese patients with hairy cell leukemia and related diseases using a quenching probe method.
    Itamura H; Ide M; Sato A; Sueoka-Aragane N; Sueoka E; Nishida A; Masunari T; Aoki S; Takizawa J; Suzumiya J; Kimura S
    Int J Hematol; 2018 Oct; 108(4):416-422. PubMed ID: 30043333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Novelties in the diagnostics and therapy of hairy cell leukemia].
    Sári E; Rajnai H; Dénes K; Bödör C; Csomor J; Körösmezey G; Tárkányi I; Eid H; Nagy Z; Demeter J
    Magy Onkol; 2016 Jun; 60(2):137-44. PubMed ID: 27275640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment.
    Maitre E; Cornet E; Troussard X
    Am J Hematol; 2019 Dec; 94(12):1413-1422. PubMed ID: 31591741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phospho-ERK(THR202/Tyr214) is overexpressed in hairy cell leukemia and is a useful diagnostic marker in bone marrow trephine sections.
    Warden DW; Ondrejka S; Lin J; Durkin L; Bodo J; Hsi ED
    Am J Surg Pathol; 2013 Feb; 37(2):305-8. PubMed ID: 23211289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hairy cell leukaemia with unusual BRAF mutations.
    Maitre E; Macro M; Troussard X
    J Cell Mol Med; 2023 Sep; 27(17):2626-2630. PubMed ID: 37530550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-time detection of BRAF V600E mutation from archival hairy cell leukemia FFPE tissue by nanopore sequencing.
    Vacca D; Cancila V; Gulino A; Lo Bosco G; Belmonte B; Di Napoli A; Florena AM; Tripodo C; Arancio W
    Mol Biol Rep; 2018 Feb; 45(1):1-7. PubMed ID: 29238890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular detection of BRAF-V600E is superior to flow cytometry for disease evaluation in hairy cell leukaemia.
    Rider T; Powell R; Gover R; Ansell R; Bastow S; Ghurye RR; Stewart H; Chevassut T
    Hematol Oncol; 2014 Sep; 32(3):158-61. PubMed ID: 24123063
    [No Abstract]   [Full Text] [Related]  

  • 33. [Molecular and therapeutic advances in Hairy cell leukemia].
    Balsat M; Cornillon J
    Bull Cancer; 2013 Oct; 100(10):1043-7. PubMed ID: 24103785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hairy cell leukemia - etiopathogenesis, diagnosis and modern therapeutic approach.
    Maćkowiak K; Jankowiak M; Szewczyk-Golec K; Hołyńska-Iwan I
    Biochem Med (Zagreb); 2024 Jun; 34(2):020502. PubMed ID: 38882583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment.
    Troussard X; Maître E; Cornet E
    Am J Hematol; 2022 Feb; 97(2):226-236. PubMed ID: 34710243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological analysis of splenic red pulp low-grade B-cell lymphoma.
    Suzuki T; Miyoshi H; Shimono J; Kawamoto K; Arakawa F; Furuta T; Yamada K; Yanagida E; Takeuchi M; Seto M; Sone H; Takizawa J; Ohshima K
    Pathol Int; 2020 May; 70(5):280-286. PubMed ID: 32052529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BRAF mutation detection in hairy cell leukaemia from archival haematolymphoid specimens.
    Thomas C; Amanuel B; Finlayson J; Grieu-Iacopetta F; Spagnolo DV; Erber WN
    Pathology; 2015 Jun; 47(4):349-54. PubMed ID: 25938346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia.
    Cornet E; Delmer A; Feugier P; Garnache-Ottou F; Ghez D; Leblond V; Levy V; Maloisel F; Re D; Zini JM; Troussard X;
    Ann Hematol; 2014 Dec; 93(12):1977-83. PubMed ID: 24994538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deciphering the genotype and phenotype of hairy cell leukemia: clues for diagnosis and treatment.
    Polderdijk MCE; Heron M; Kuipers S; Rijkers GT
    Expert Rev Clin Immunol; 2019 Aug; 15(8):857-867. PubMed ID: 31282776
    [No Abstract]   [Full Text] [Related]  

  • 40. Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation.
    Xi L; Arons E; Navarro W; Calvo KR; Stetler-Stevenson M; Raffeld M; Kreitman RJ
    Blood; 2012 Apr; 119(14):3330-2. PubMed ID: 22210875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.